Real world long-term outcomes in patients with mucopolysaccharidosis type II: A retrospective cohort study.
Ontology highlight
ABSTRACT: We investigated the decline of activities of daily living with symptomatic progression in patients with mucopolysaccharidosis type II (MPS II) and investigated the associated factors. Clinical data were retrospectively collected from the medical records of 28 patients with MPS II who visited our hospital between October 2007 and August 2019. Activities of daily living were assessed over time using a 5-point scale (from stage 1, indicating independent, to stage 5, indicating total assistance + medical care); the relationships of the interval years from stage 2 (mild symptoms) to stage 4 (total assistance) with therapeutic intervention, anti-drug antibodies (ADA), urinary glycosaminoglycans (uGAG), and genotypes were analyzed. Eight are attenuated types, and 20 are severe types. Further, 20
SUBMITTER: Tomita K
PROVIDER: S-EPMC8554623 | biostudies-literature | 2021 Dec
REPOSITORIES: biostudies-literature
ACCESS DATA